最新消息
最新消息
HIMSS讚譽中醫大附醫 全球智慧醫院新興模範 榮登HIMSS《INSIGHTS》雜誌 亞洲版封面故事
2024/1/11美國醫療資訊暨管理系統協會(Healthcare Information and Management Systems Society,簡稱為HIMSS)是全球醫療機構智慧醫療的高品質指標,中國醫藥大學附設醫院歷經努力,今年初榮獲HIMSS「數位健康指標
China Medical University Hospital:Driving smart hospital transformation with data and AI
2023/12/29HIMSS is a globally renowned Healthcare Information and Management Systems Society. CMUH is very much honored to receive outstanding performance by HIMSS certification. CMUH transformation with data and AI was featured on the cover story of the HIMM's publication, 'INSIGHTS' magazine, the Asia-Pacific edition in December,2023.
With Digital Transformation, the CMUH Honored as One of the Top Three Smart Hospitals Accredited with Convincing Performance in US HIMSS “Digital Health Indicators”
2023/2/6Under the leadership of Superintendent Der-Yang Cho and the unrelenting effort of the elite teams of China Medical University Hospital, their clinical practice powered by smart healthcare impressed the panel, and they were honored as one of the top three smart hospitals in the world for being accredited with convincing performance in “digital health indicators” by HIMSS,
醫起健康遊台灣-馬國古晉舉辦健康諮詢講座
2022/8/3醫起健康遊台灣-重難罕症.癌症細胞治療.醫療AI 海外就醫新選擇 中國附醫推廣世界級特色醫療 省時高效率一站式服務 嘉惠馬國民眾 中國醫藥大學附設醫院主辦,砂拉越古晉三馬拉漢及西連省華人社團總會及砂拉越留臺同學會古晉分會協辦“醫起健康遊台灣”諮詢講座會2022年8月19日(星期五)晚上7:30,於馬來西亞古晉 Lot 10 Boutique Hotel舉行。 廣大關心健康的馬來西亞民眾,有福了!台灣國際醫療領導品牌-中國醫藥大學附設醫院(中國附醫)在台灣政府支持下,首度將世界級,治療重難罕症、癌症細胞治療、醫療AI的尖端醫療技術與國際醫療服務,推廣到砂拉越、沙巴地區。中國附醫將於19日,首次於古晉舉辦一場「醫起健康遊台灣」健康諮詢講座,由中國附醫四位醫師、專家群,就尖端特色醫療、癌症細胞治療、幹細胞健康應用與赴台就醫服務四大面向,與民眾面對面分享。
Radiotherapy(RT) and Immunotherapy: The Synergistic Combination
2018/7/4Novel treatment trend for cancer - Combining radiotherapy and immunotherapy synergistically enhances local and systemic tumor control.
Western Medicine and Chinese Medicine Working in Harmony Positive Effects by Neoadjuvant Therapy for Breast Cancer
2017/3/1Breast Cancer is the most common cancer among women in Taiwan. In recent years, there are more and more younger women who are diagnosed with breast cancer.